Fibrates in 2018: story goes on
At present, pharmacological intervention for dyslipidemia (DLP) is primarily aimed at the effect of LDL-C statins. In monotherapy then possibly in combination with ezetimibe (or...
Authors: Richard Češka, Michal Vrablík, Tomáš Štulc
Lysosomal storage disorders as the cause of dyslipoproteinemia
Lysosomal storage disorders (LSDs) belong to group of rare, inborn, inherited diseases. They are caused by insufficient activity of certain lysosomal enzymes, by error of a...
Authors: Anna Hlavatá, Katarína Juríčková
Detection of aortic calcifications within the assessment of lateral densitometric scans
Cardiovascular morbidity and mortality still remain one of the main actual problems of modern medicine. Latterly, raising amounts of data are published on evaluation of...
Authors: Daniel Čierny, Kristína Brázdilová, Zdenko Killinger, Juraj Payer
Secondary and adverse effects of antihypertensive drugs
It includes a brief overview of secondary and unwanted effects of basic antihypertensive drugs which may influence patients toward discontinuation of medication with the ensuing...
Authors: Jiří Vítovec, Jindřich Špinar
Arterial hypertension – a risk factor for sudden vascular stroke
Strokes are among the most common causes of morbidity and mortality, and in individuals who suffered stroke, subsequent long-term neurological deficit in a larger or smaller...
Authors: Ľudovít Gašpar, Andrea Komorníková, Veronika Vestenická
Peripheral arterial disease of lower extremity and global cardiovascular risk
Peripheral arterial disease (PAD) of lower extremity is predominantly a manifestation of atherothrombotic process. Effective cardiovascular risk treatment is underestimated in...
Authors: Denisa Čelovská, Viera Štvrtinová
Perspectives on central systolic pressure in clinical practice
The basic characteristic of blood circulation in humans is given by the cyclical work of the heart, which ejects the blood pulse volume into the arteries. The workload of left...
Authors: Mária Potočárová, Jozef Bulas, Viera Kupčová, Marta Filková, Ján Murín
Secondary dyslipidemia (DLP) arises as a result of other diseases or various exogenous influences. However, genetic predisposition, as it is known in the case of primary DLP...
Authors: Martin Šatný, Michal Vrablík
Intensive treatment of dyslipidemia in regional outpatient cardiology office
We presented briefly initial experiences of outpatient cardiologist in the first ever MedPed center in the Orava region. Reduction of low-density lipoprotein cholesterol (LDL...
The role of functional food and nutraceuticals in therapy of hypercholesterolemia
Dyslipidemia, arterial hypertension, smoking and type 2 diabetes mellitus are the most important risk factors for cardiovascular diseases (CVD). The first step in treatment of...
SubscriptionSubscribe the Journal
The subscription grants you full access to all the articles.
Issue No.: 3 / 2018
- Fats in foods from health point of view | views: 655
- The role of functional food and nutraceuticals in therapy of hypercholesterolemia | views: 158
- Opinion of the Committee of the Czech Society for Atherosclerosis on the ESC/ EAS Recommendations for Dyslipidemia Diagnostics and Treatment 2016 | views: 155
- Secondary dyslipidemia | views: 153
- Intensive treatment of dyslipidemia in regional outpatient cardiology office | views: 149